Remedy Pharmaceuticals Garners $1,379,587 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=717acb18-98c0-4d7d-a321-d176430ff493&Preview=1
Date
7/9/2012
Company Name
Remedy Pharmaceuticals
Mailing Address
802 6th Avenue New York, NY 10001
Company Description
Remedy Pharmaceuticals, Inc. is a clinical stage company developing small molecule drugs targeting NCCa-ATP channels in acute central nervous system injury including traumatic brain injury, stroke, and spinal cord injury.
Website
http://www.remedypharmaceuticals.com
Transaction Type
Venture Equity
Transaction Amount
$1,379,587
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed